Oncología Hepática
Publications (7) Publications in which a researcher has participated
filter_list
Cancer Research
2025
-
Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study
The Lancet, Vol. 405, Núm. 10474, pp. 216-232
-
Phosphatidylserine as a tumor target for CAR-T cell therapy
Journal for ImmunoTherapy of Cancer, Vol. 13, Núm. 2
2024
-
Comprehensive in silico CpG methylation analysis in hepatocellular carcinoma identifies tissue- and tumor-type specific marks disconnected from gene expression
Journal of Physiology and Biochemistry, Vol. 80, Núm. 4, pp. 865-879
-
Identification of PRMT5 as a therapeutic target in cholangiocarcinoma
Gut, Vol. 74, Núm. 1, pp. 116-127
-
Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH-AEG-SEPD-SEOM-GETECCU
Revista espanola de enfermedades digestivas, Vol. 116, Núm. 2, pp. 83-113
-
PET/CT FAPI: Procedure and evidence review in oncology
Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 43, Núm. 2, pp. 130-140
-
Survival and safety after neoadjuvant chemotherapy or upfront surgery for locally advanced colon cancer: meta-analysis
British Journal of Surgery, Vol. 111, Núm. 2